Back to the complete issue
Monday, 3 January 2022

Pfizer’s covid pill is coming to Egypt, more than 35% of us are now fully or partially jabbed

Leading the conversation on the airwaves last night: Pfizer’s covid pill is coming to Egypt. Egypt has agreed with Pfizer to purchase its Paxlovid oral anti-coronavirus med, interim health minister Khaled Abdel Ghaffar said in an interview on El Hekaya last night (watch, runtime: 2:45). Under the agreement, the US pharma giant will provide enough medication to treat 20k people, the minister said, adding that the pills will arrive in the “coming weeks.”

A handful of countries have approved the experimental antiviral med for use: A UK regulator last week approved it to treat mild to moderate covid symptoms in people aged 18 and above who are at risk of developing severe illness, following the US, which gave the go-ahead late last year for high-risk covid patients aged 12.

Egypt isn’t one of them: The Egyptian Meds. Authority is yet to approve Paxlovid for use in Egypt.

What is Paxlovid? It’s an experimental med created by Pfizer to treat mild-to-moderate covid-19. It consists of two separate pills — nirmatrelvir and ritonavir— that are taken twice daily for five days.

More than 21.6 mn Egyptians are now fully vaccinated against covid-19, while another 13.6 mn people have received their first dose, according to figures provided by Abdel Ghaffar (watch, runtime: 2:07).

The damage left by last week’s bad weather also got a lot of attention: Kelma Akhira’s Lamees El Hadidi (watch, runtime: 3:23), El Hekaya’s Amr Adib (watch, runtime: 6:45) and Ala Mas’ouleety’s Ahmed Moussa (watch, runtime: 1:17:16) all had coverage.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.